CCS
ALXN

Crosspoint Capital Strategies’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Crosspoint Capital Strategies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$37K – 892
2015
Q4 		$37K Buy
+200
New +$37K 0.01% 488